ArticleActa anaesthesiologica Scandinavica2025
The 1-Year Functional Recovery From Severe COVID-19 in a Swedish Working-Age Cohort.
Article in Acta anaesthesiologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05054608 (Long Term Outcome in ICU Treated COVID-19), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Long Term Outcome in ICU Treated COVID-19: Return to Work
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundLong-term symptoms are common after the acute phase of COVID-19. We hypothesized that sick leave as an estimate of functional recovery, adjusted for confounding, differs between intensive care unit (ICU) and hospitalized COVID-19 patients and population controls.
methodsIn this cohort study, we identified all working-age individuals with COVID-19 admitted to ICUs or hospitals until July 20, 2020 from national registries. Matched population controls were randomly assigned to each ICU patient. Using logistic regression to adjust for confounding, we compared ICU patients to hospital patients and population controls on the number of sick leave-free days alive during the first year after hospital discharge and the proportion of alive individuals on sick leave after 1 year.
resultsWe included 1020 COVID-19 ICU patients, 5306 COVID-19 hospital patients, and 4387 population controls. The ICU patients had a median of 271 (interquartile range, 33-349) sick leave-free days alive, while hospital patients had 354 (334-365) and population controls 365 (365-365). ICU patients had an odds ratio (OR) of 0.14 (0.12-0.16, 95% confidence interval) compared to hospital patients, and 0.02 (0.02-0.03, both p < 0.001) compared to population controls for at least one more sick leave-free day alive. Being on sick leave 1 year after inclusion had similar but inverse ORs.
conclusionThis national cohort study, in ICU and hospitalized patients with COVID-19, shows that the severity of COVID-19 disease, functional and health status before COVID-19, and demographic factors had a major impact on recovery.
trial registrationNCT05054608.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.